![\"\"](\"https:\/\/inprojournal.org\/wp-content\/uploads\/2023\/03\/018-cover-734x1024.jpg\")
<\/figure>\n\n\n\nTheory and practice of intellectual property
\u2116 3 \/ 2023<\/p>\n\n\n\n
ISSN (Print) 2308-0361
ISSN (Online) 2519-2744<\/p>\n\n\n\n
![\"\"](\"https:\/\/test.inprojournal.org\/wp-content\/uploads\/2023\/01\/free-icon-pdf-201153.png\"){kind=icon}
PDF (Ukrainian)<\/a><\/div>\n<\/div>\n\n\n\nDOI: https:\/\/doi.org\/10.33731\/32023.282330<\/a><\/p>\n\n\n\n Submitted 2023-05-11 <\/p>\n\n\n\n <\/p>\n<\/div>\n\n\n\n Intellectual property rights in the context of biology, medicine and pharmacy: a look into the future<\/strong><\/p>\n\n\n\n Olha Omelchenko<\/strong> <\/p>\n\n\n\n Abstract The article analyzes the modern trends in the protection of intellectual property rights to biotechnology inventions at an international level, and forecasts the likely subsequent development in legal protection of intellectual property rights in the areas of biology, medicine and pharmacy in view of the ever increasing ethical and law controversies of medical and biological research in some areas, the emergence of big data, use of artificial intelligence, etc.<\/p>\n\n\n\n The national legislation refers to the term \u00abbiotechnology\u00bb in the Law of Ukraine \u00abOn Environmental Protection\u00bb, while not giving any legal definition of \u00abbiotechnology\u00bb in any laws. The Ukrainian intellectual property and health care legislation require reformation to get properly updated to respond to the ongoing challenges. There is a whole layer of gaps regarding the legal regulation of using biotechnology in Ukraine, and this extends to all areas where biotechnology is actually integrated. The use of biotechnology in biology, medicine, and pharmacy requires a systemic and multiaspect study in order to develop the appropriate legal norms.<\/p>\n\n\n\n To ensure the stability of the pharmaceutical market, which is focused on the national manufacturer, it is necessary to create the proper conditions for the development of a high-tech research environment in Ukraine. It is necessary to improve national legislation in the field of biobanking and the legal regime of human biological material Keywords: <\/strong>intellectual property rights, biobank, biotechnology, legal regulation, pharmacy<\/p>\n\n\n\n References<\/strong><\/p>\n\n\n\n Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions Making the most of the EU\u2019s innovative potential An intellectual property action plan to support the EU\u2019s recovery and resilience. \u041a\u043e\u043d\u0432\u0435\u043d\u0446\u0456\u044f \u043f\u0440\u043e \u043e\u0445\u043e\u0440\u043e\u043d\u0443 \u0431\u0456\u043e\u043b\u043e\u0433\u0456\u0447\u043d\u043e\u0433\u043e \u0440\u0456\u0437\u043d\u043e\u043c\u0430\u043d\u0456\u0442\u0442\u044f \u0432\u0456\u0434 1992 \u0440\u043e\u043a\u0443. \u041a\u0430\u0440\u0442\u0430\u0445\u0435\u043d\u0441\u044c\u043a\u0438\u0439 \u043f\u0440\u043e\u0442\u043e\u043a\u043e\u043b \u043f\u0440\u043e \u0431\u0456\u043e\u0431\u0435\u0437\u043f\u0435\u043a\u0443 \u0434\u043e \u041a\u043e\u043d\u0432\u0435\u043d\u0446\u0456\u0457 \u043f\u0440\u043e \u0431\u0456\u043e\u043b\u043e\u0433\u0456\u0447\u043d\u0435 \u0440\u0456\u0437\u043d\u043e\u043c\u0430\u043d\u0456\u0442\u0442\u044f. \u0414\u0438\u0440\u0435\u043a\u0442\u0438\u0432\u0438 98\/44\/\u0404\u0421 \u0404\u0432\u0440\u043e\u043f\u0435\u0439\u0441\u044c\u043a\u043e\u0433\u043e \u041f\u0430\u0440\u043b\u0430\u043c\u0435\u043d\u0442\u0443 \u0442\u0430 \u0420\u0430\u0434\u0438 \u0432\u0456\u0434 6 \u043b\u0438\u043f\u043d\u044f 1998 \u0440\u043e\u043a\u0443 \u043f\u0440\u043e \u043f\u0440\u0430\u0432\u043e\u0432\u0438\u0439 \u0437\u0430\u0445\u0438\u0441\u0442 \u0431\u0456\u043e\u0442\u0435\u0445\u043d\u043e\u043b\u043e\u0433\u0456\u0447\u043d\u0438\u0445 \u0432\u0438\u043d\u0430\u0445\u043e\u0434\u0456\u0432. \u041f\u0440\u043e \u043e\u0445\u043e\u0440\u043e\u043d\u0443 \u043d\u0430\u0432\u043a\u043e\u043b\u0438\u0448\u043d\u044c\u043e\u0433\u043e \u043f\u0440\u0438\u0440\u043e\u0434\u043d\u043e\u0433\u043e \u0441\u0435\u0440\u0435\u0434\u043e\u0432\u0438\u0449\u0430: \u0417\u0430\u043a\u043e\u043d \u0423\u043a\u0440\u0430\u0457\u043d\u0438 \u0432\u0456\u0434 25.06.1991 \u0440. \u2116 1264-XII. \u041f\u0440\u043e \u0437\u0430\u0442\u0432\u0435\u0440\u0434\u0436\u0435\u043d\u043d\u044f \u041b\u0456\u0446\u0435\u043d\u0437\u0456\u0439\u043d\u0438\u0445 \u0443\u043c\u043e\u0432 \u043f\u0440\u043e\u0432\u0430\u0434\u0436\u0435\u043d\u043d\u044f \u0433\u043e\u0441\u043f\u043e\u0434\u0430\u0440\u0441\u044c\u043a\u043e\u0457 \u0434\u0456\u044f\u043b\u044c\u043d\u043e\u0441\u0442\u0456 \u0431\u0430\u043d\u043a\u0456\u0432 \u043f\u0443\u043f\u043e\u0432\u0438\u043d\u043d\u043e\u0457 \u043a\u0440\u043e\u0432\u0456, \u0456\u043d\u0448\u0438\u0445 \u0442\u043a\u0430\u043d\u0438\u043d \u0456 \u043a\u043b\u0456\u0442\u0438\u043d \u043b\u044e\u0434\u0438\u043d\u0438 \u0437\u0433\u0456\u0434\u043d\u043e \u0437 \u043f\u0435\u0440\u0435\u043b\u0456\u043a\u043e\u043c, \u0437\u0430\u0442\u0432\u0435\u0440\u0434\u0436\u0435\u043d\u0438\u043c \u041c\u0456\u043d\u0456\u0441\u0442\u0435\u0440\u0441\u0442\u0432\u043e\u043c \u043e\u0445\u043e\u0440\u043e\u043d\u0438 \u0437\u0434\u043e\u0440\u043e\u0432\u2019\u044f: \u043f\u043e\u0441\u0442\u0430\u043d\u043e\u0432\u0430 \u041a\u0430\u0431\u0456\u043d\u0435\u0442\u0443 \u041c\u0456\u043d\u0456\u0441\u0442\u0440\u0456\u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0438 \u0432\u0456\u0434 2 \u0431\u0435\u0440\u0435\u0437\u043d\u044f 2016 \u0440. \u2116 286. Sweden to implement a new Biobanks Act. Imaging study. Kinkorova J., Topolcan O. Biobanks in the era of big data: objectives, challenges, perspectives, and innovations for predictive, preventive, and personalised medicine. The EPMA Journal. 2020. Vol. 11(3). A review of big data and medical research. Big data. Data Act: MEPs back new rules for fair access to and use of industrial data. Proposal for a Regulation of the European Parliament and of the Council on Harmonised Rules on Fair Access to and Use of Data (Data Act). \u041f\u0440\u043e \u0430\u0432\u0442\u043e\u0440\u0441\u044c\u043a\u0435 \u043f\u0440\u0430\u0432\u043e \u0456 \u0441\u0443\u043c\u0456\u0436\u043d\u0456 \u043f\u0440\u0430\u0432\u0430: \u0417\u0430\u043a\u043e\u043d \u0423\u043a\u0440\u0430\u0457\u043d\u0438 \u0432\u0456\u0434 01.12.2022 \u0440. \u2116 2811-IX. The Interplay of Big Data and Intellectual Property Rights. Cyranoski D., Contreras J. L., Carrington V. T. Intellectual property and assisted reproductive technology. Nature Biotechnology. 2023. Vol. 41. P. 14\u201320. Biomedicine, self and society: An agenda for collaboration and engagement \/ M. Pickersgill et al. Wellcome Open Research. \u0424\u0435\u0434\u043e\u0442\u043e\u0432\u0430 \u0413., \u0424\u0438\u043b\u044c \u0421. \u041e\u0445\u043e\u0440\u043e\u043d\u0430 \u043f\u0440\u0430\u0432 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456 \u0432 \u0433\u0430\u043b\u0443\u0437\u0456 \u0431\u0456\u043e\u0442\u0435\u0445\u043d\u043e\u043b\u043e\u0433\u0456\u0439. \u0422\u0435\u043e\u0440\u0456\u044f \u0456 \u043f\u0440\u0430\u043a\u0442\u0438\u043a\u0430 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456. 2021. \u2116 6. \u0421. 38\u221248.<\/p>\n\n\n\n \u041f\u0440\u043e \u043e\u0445\u043e\u0440\u043e\u043d\u0443 \u043f\u0440\u0430\u0432 \u043d\u0430 \u0432\u0438\u043d\u0430\u0445\u043e\u0434\u0438 \u0456 \u043a\u043e\u0440\u0438\u0441\u043d\u0456 \u043c\u043e\u0434\u0435\u043b\u0456: \u0417\u0430\u043a\u043e\u043d \u0423\u043a\u0440\u0430\u0457\u043d\u0438 \u0432\u0456\u0434 23 \u0433\u0440\u0443\u0434\u043d\u044f 1993 \u0440. \u2116 3769-XII. Kataoka M., Lee T.-L., Sawai T. The legal personhood of human brain organoids. Journal of Law and the Biosciences. 2023. Vol. 10, no. 1. The Role of Patents and Licensing in the Governance of Human Genome Editing: A White Paper\/ D. Matthews et al. Queen Mary Law Research Paper. 2021. No 364. Minssen T., Mimler M. Patenting Bioprinting-Technologies in the US and Europe \u2014 The 5th Element in the 3rd Dimension \/ Minssen Timo; Mimler Marc. 3D printing, Intellectual Property and Innovation \u2013 Insights from Law and Technology. ed. \/ Rosa Maria Ballardini; Marcus Norrg\u00e5rd; Jouni Partanen. Wolters Kluwer, 2017. \u041f\u043e\u043d\u043e\u043c\u0430\u0440\u044c\u043e\u0432\u0430 \u041e. \u0414\u043e\u0441\u0432\u0456\u0434 \u043a\u0440\u0430\u0457\u043d \u0404\u0421 \u0449\u043e\u0434\u043e \u0435\u0442\u0438\u0447\u043d\u0438\u0445 \u0430\u0441\u043f\u0435\u043a\u0442\u0456\u0432 \u043f\u0430\u0442\u0435\u043d\u0442\u0443\u0432\u0430\u043d\u043d\u044f \u0431\u0456\u043e\u0442\u0435\u0445\u043d\u043e\u043b\u043e\u0433\u0456\u0439 \u0443 \u0441\u0444\u0435\u0440\u0456 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0438 \u0456 \u0444\u0430\u0440\u043c\u0430\u0446\u0456\u0457. \u0422\u0435\u043e\u0440\u0456\u044f \u0456 \u043f\u0440\u0430\u043a\u0442\u0438\u043a\u0430 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456. 2021. \u2116 1. \u0421. 23\u221228.<\/p>\n\n\n\n McMahon A. Biotechnology, Health and Patents as Private Governance Tools: the Good, the Bad and the Potential for Ugly? Intellectual Property Quarterly. 2020. Vol. 3. P. 161\u2013179. \u0423\u0433\u043e\u0434\u0430 \u043f\u0440\u043e \u0442\u043e\u0440\u0433\u043e\u0432\u0435\u043b\u044c\u043d\u0456 \u0430\u0441\u043f\u0435\u043a\u0442\u0438 \u043f\u0440\u0430\u0432 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456 \u0432\u0456\u0434 15 \u043a\u0432\u0456\u0442\u043d\u044f 1994 \u0440. \u0412\u0435\u043b\u0438\u0447\u043a\u043e \u0414. \u041c., \u0427\u0435\u043d\u0448\u043e\u0432\u0430 \u041d. \u0412. \u0427\u0435\u0442\u0432\u0435\u0440\u0442\u0435 \u043f\u043e\u043a\u043e\u043b\u0456\u043d\u043d\u044f \u043f\u0440\u0430\u0432 \u043b\u044e\u0434\u0438\u043d\u0438 \u0443 \u0441\u0444\u0435\u0440\u0456 \u043e\u0445\u043e\u0440\u043e\u043d\u0438 \u0437\u0434\u043e\u0440\u043e\u0432\u2019\u044f: \u043e\u0441\u043e\u0431\u043b\u0438\u0432\u043e\u0441\u0442\u0456 \u0441\u0442\u0430\u043d\u043e\u0432\u043b\u0435\u043d\u043d\u044f \u0442\u0430 \u0441\u0443\u0447\u0430\u0441\u043d\u0438\u0439 \u0441\u0442\u0430\u043d \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0456. \u041f\u0440\u0430\u0432\u043e \u0456 \u0441\u0443\u0441\u043f\u0456\u043b\u044c\u0441\u0442\u0432\u043e. 2023. \u2116 1. \u0421. 3\u22129.<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":" Theory and practice of intellectual property\u2116 3 \/ 2023 ISSN (Print) 2308-0361ISSN (Online) 2519-2744 DOI: https:\/\/doi.org\/10.33731\/32023.282330 Submitted 2023-05-11Accepted 2023-05-25Published 2023-06-19 Intellectual property rights in the context of biology, medicine and pharmacy: a look into the future Olha OmelchenkoPh.D. (Law), researcher at the Department for Research on Intellectual Property Rights and Human Rights […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-8707","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/pages\/8707","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/comments?post=8707"}],"version-history":[{"count":3,"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/pages\/8707\/revisions"}],"predecessor-version":[{"id":8710,"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/pages\/8707\/revisions\/8710"}],"wp:attachment":[{"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/media?parent=8707"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Accepted 2023-05-25
Published 2023-06-19<\/p>\n\n\n\n![\"\"](\"https:\/\/inprojournal.org\/wp-content\/uploads\/2025\/11\/CC-2.png\")
<\/figure>\n\n\n\n
Ph.D. (Law), researcher at the Department for Research on Intellectual Property Rights and Human Rights in Healthcare of the Intellectual Property Scientific Research Institute of the National Academy of Legal Sciences of Ukraine
Ukraine
https:\/\/orcid.org\/0000-0002-3265-205X<\/a><\/p>\n\n\n\n
<\/strong>The article covers the study of some aspects of protecting intellectual property rights in the areas of biology, medicine, and pharmacy, including biotechnological inventions. The rapid progress of science and technology, the generation and accumulation of knowledge, and the possibilities to process large amounts of various data further stimulate the development of all social areas and unprecedentedly contribute to the emergence of innovations, in particular in the area of biotechnology. Intellectual property rights have a direct impact on the progress of medical and biological research, but increasingly require coordination with the ethical and moral principles of society regarding the patentability of inventions in biology, medicine, and pharmacy.<\/p>\n\n\n\n
for the purpose of using it in research.<\/p>\n\n\n\n
https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A52020DC0760<\/a><\/p>\n\n\n\n
https:\/\/zakon.rada.gov.ua\/go\/995_030<\/a><\/p>\n\n\n\n
https:\/\/zakon.rada.gov.ua\/go\/995_935<\/a><\/p>\n\n\n\n
https:\/\/eur- lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A31998L0044<\/a><\/p>\n\n\n\n
https:\/\/zakon.rada.gov.ua\/go\/1264-12<\/a><\/p>\n\n\n\n
https:\/\/zakon.rada.gov.ua\/laws\/show\/286-2016-%D0%BF<\/a><\/p>\n\n\n\n
https:\/\/sweden.dlapiper.com\/en\/news\/sweden-implement-new-biobanks-act<\/a><\/p>\n\n\n\n
https:\/\/www.ukbiobank.ac.uk\/explore-your-participation\/contribute-further\/imaging-study<\/a><\/p>\n\n\n\n
https:\/\/doi.org\/10.1007\/s13167-020-00213-2<\/a><\/p>\n\n\n\n
https:\/\/journals.sagepub.com\/doi\/full\/10.1177\/2050312120934839<\/a><\/p>\n\n\n\n
https:\/\/digital-strategy.ec.europa.eu\/en\/policies\/big-data<\/a><\/p>\n\n\n\n
https:\/\/www.europarl.europa.eu\/news\/en\/press-room\/20230310IPR77226\/data-act-meps-back-new-rules-for-fair-access-to-and-use-of-industrial-data<\/a><\/p>\n\n\n\n
https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A52022PC0068<\/a><\/p>\n\n\n\n
https:\/\/zakon.rada.gov.ua\/go\/2811-20<\/a><\/p>\n\n\n\n
https:\/\/www.kashishipr.com\/blog\/the-interplay-of-big-data-and-intellectual-property-rights\/<\/a><\/p>\n\n\n\n
https:\/\/doi.org\/10.1038\/s41587-022-01592-9<\/a><\/p>\n\n\n\n
https:\/\/wellcomeopenresearch.org\/articles\/4-9\/v1<\/a><\/p>\n\n\n\n
https:\/\/zakon.rada.gov.ua\/laws\/show\/3687-12<\/a><\/p>\n\n\n\n
https:\/\/doi.org\/10.1093\/jlb\/lsad007<\/a><\/p>\n\n\n\n
https:\/\/ssrn.com\/abstract=3896308<\/a><\/p>\n\n\n\n
https:\/\/ssrn.com\/abstract=2946209<\/a><\/p>\n\n\n\n
https:\/\/doi.org\/10.2139\/ssrn.4002479<\/a><\/p>\n\n\n\n
https:\/\/zakon.rada.gov.ua\/laws\/show\/981_018<\/a><\/p>\n\n\n\n